| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/31/2001 | EP1071788A1 Novel nucleic acids and polypeptides related to a farnesyl-directed cysteine carboxymethyltransferase |
| 01/31/2001 | EP1071787A1 Tao protein kinases and methods of use |
| 01/31/2001 | EP1071786A2 Genetically engineered yeast and mutants thereof for the efficient fermentation of lignocellulose hydrolysates |
| 01/31/2001 | EP1071785A2 Interconversion of plant fatty acid desaturases and hydroxylases |
| 01/31/2001 | EP1071784A1 Polypeptides from moraxella (branhamella) catarrhalis |
| 01/31/2001 | EP1071783A2 Basb006 polynucleotide(s) and polypeptides from neisseria meningitis |
| 01/31/2001 | EP1071782A2 Seed-coat promoters, genes and gene products |
| 01/31/2001 | EP1071781A1 B-cell growth factor related protein |
| 01/31/2001 | EP1071780A1 Soluble protein ztmpo-1 |
| 01/31/2001 | EP1071779A1 Vertebrate patched-2 protein |
| 01/31/2001 | EP1071778A2 Srebp-2-deficient cell lines |
| 01/31/2001 | EP1071777A2 Human nucleic acid sequences of normal uterus tissue |
| 01/31/2001 | EP1071776A2 Human nucleic acid sequences of normal bladder tissue |
| 01/31/2001 | EP1071775A2 Human nucleic acid sequences of endometrium tumour tissue |
| 01/31/2001 | EP1071774A2 Isolated sh3 genes associated with myeloproliferative disorders and leukemia, and uses thereof |
| 01/31/2001 | EP1071773A1 Sh2 domain-containing peptides |
| 01/31/2001 | EP1071772A2 Fizz proteins |
| 01/31/2001 | EP1071771A2 Gene encoding syntaxin interacting protein |
| 01/31/2001 | EP1071770A2 Glaucoma therapeutics and diagnostics based on a novel human transcription factor |
| 01/31/2001 | EP1071769A1 Secretion of glycosylated proteins using a tissue plasminogen activator pro-sequence |
| 01/31/2001 | EP1071768A1 Delivery of therapeutic proteins via implantation of genetically modified cells in the omentum |
| 01/31/2001 | EP1071767A1 Gene coding for heliomicine and use thereof |
| 01/31/2001 | EP1071766A1 HUMAN G-PROTEIN COUPLED RECEPTOR GPR6sb |
| 01/31/2001 | EP1071765A1 Alk-1 responds to tgf-beta and signals through smad-1 and smad-5 |
| 01/31/2001 | EP1071764A1 ANTISENSE OLIGONUCLEOTIDES FOR THE INHIBITION OF INTEGRIN $g(a) v?-SUBUNIT EXPRESSION |
| 01/31/2001 | EP1071763A1 Vaccine formulations comprising antiidiotypic antibodies which immunologically mimic group b streptococcal carbohydrates |
| 01/31/2001 | EP1071762A1 Control of gene expression |
| 01/31/2001 | EP1071761A1 Mutants of the mycobacterium species and use of the same for screening for antibiotics vectors |
| 01/31/2001 | EP1071760A1 Genetically modified lactic acid bacteria having modified diacetyl reductase activities |
| 01/31/2001 | EP1071758A1 Porcine adenovirus type 3 genome |
| 01/31/2001 | EP1071757A2 Combination of genes for regulating flowering induction in useful and ornamental plants |
| 01/31/2001 | EP1071756A1 PURIFICATION OF HUMAN ACID $g(a)-GLUCOSIDASE |
| 01/31/2001 | EP1071755A1 Human bile salt-stimulated lipase (bssl) obtainable from transgenic sheep |
| 01/31/2001 | EP1071754A1 Recombinant secoisolariciresinol dehydrogenase, and methods of use |
| 01/31/2001 | EP1071753A2 Nucleic acid molecules with novel chemical compositions capable of modulating gene expression |
| 01/31/2001 | EP1071752A1 CD19xCD3 SPECIFIC POLYPEPTIDES AND USES THEREOF |
| 01/31/2001 | EP1071751A1 TRANSGENIC MAMMALS EXPRESSING MUTANT GP IIIa |
| 01/31/2001 | EP1071750A1 Pns cell lines and methods of use therefor |
| 01/31/2001 | EP1071749A1 Novel lrsg protein and nucleic acid molecules and uses therefor |
| 01/31/2001 | EP1071748A1 EXPRESSION OF $i(ALFIN1) AND METHODS FOR PRODUCING TRANSGENIC PLANTS HAVING INCREASED ROOT GROWTH AND ROOT SPECIFIC GENE ACTIVATION |
| 01/31/2001 | EP1071747A2 Immortalised cell lines derived from normal human skin tissues |
| 01/31/2001 | EP1071746A2 Process for preparing doxorubicin |
| 01/31/2001 | EP1071718A1 Matrix binding factor |
| 01/31/2001 | EP1071717A1 Mutagenized il13-based chimeric molecules |
| 01/31/2001 | EP1071715A2 TRANSFERRIN RECEPTOR GENES OF $i(MORAXELLA) |
| 01/31/2001 | EP1071714A1 A novel g-protein coupled receptor |
| 01/31/2001 | EP1071711A1 Process for the recovery and purification of a recombinant protein from a cell |
| 01/31/2001 | EP1071710A2 Genomic sequence of the 5-lipoxygenase-activating protein (flap), polymorphic markers thereof and methods for detection of asthma |
| 01/31/2001 | EP1071709A2 Dermatophagoides nucleic acid molecules, proteins and uses thereof |
| 01/31/2001 | EP1071708A1 Edg family gene, human h218 |
| 01/31/2001 | EP1071707A1 Novel omega conotoxin peptides |
| 01/31/2001 | EP1071706A1 Rapidly degrading gfp-fusion proteins and methods of use |
| 01/31/2001 | EP1071705A2 Peptides causing formation of compact structures |
| 01/31/2001 | EP1071701A1 Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof |
| 01/31/2001 | EP1071700A1 Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity |
| 01/31/2001 | EP1071699A1 Enhanced antisense modulation of icam-1 |
| 01/31/2001 | EP1071698A1 Nucleic acid sequences and proteins associated with aging |
| 01/31/2001 | EP1071697A1 Regulated target expression for screening |
| 01/31/2001 | EP1071696A1 Programmed cell death and caspase-12 |
| 01/31/2001 | EP1071695A1 Endotoxin reduction in nucleic acid purification |
| 01/31/2001 | EP1071694A1 Staphylococcus aureus spo0j2: polynucleotide and protein |
| 01/31/2001 | EP1071691A1 Method for isolating and purifying nucleic acids |
| 01/31/2001 | EP1071472A1 Peptides for efficient gene transfer |
| 01/31/2001 | EP1071471A2 Methods and vector constructs for making transgenic non-human animals which ubiquitously express a heterologous gene |
| 01/31/2001 | EP1071460A1 INTERNALIZING ErbB2 ANTIBODIES |
| 01/31/2001 | EP1071459A1 Methods to provoke anti-cancer immune responses |
| 01/31/2001 | EP1071458A1 Humanized antibody and uses thereof |
| 01/31/2001 | EP1071451A2 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 01/31/2001 | EP1071443A1 Isolated peptides corresponding to amino acid sequences of ny-eso-1, wherein bind to mhc class i and mhc class ii molecules, and uses thereof |
| 01/31/2001 | EP1071436A1 Immune effector cell hybrids |
| 01/31/2001 | EP1071434A1 Cnre binding factors and uses thereof |
| 01/31/2001 | EP1071429A1 Map kinase inhibitors in the treatment of disorders caused by tnf-alpha induced lipolysis |
| 01/31/2001 | EP1071412A2 Identification of bacterial avirulence genes and their products; vaccines and pharmaceutical compositions containing them |
| 01/31/2001 | EP1071377A1 Needleless administration of polynucleotide formulations |
| 01/31/2001 | EP1071334A1 A method for efficient and highly selective control of microorganisms |
| 01/31/2001 | EP1071321A1 Source of nuclei for nuclear transfer |
| 01/31/2001 | EP0943017B1 Diagnostic assay for breast cancer susceptibility |
| 01/31/2001 | EP0724639B1 Methods for selection of recombinant host cells expressing high levels of a desired protein |
| 01/31/2001 | EP0706569B1 Sbp members with a chemical moiety covalently bound within the binding site; production and selection thereof |
| 01/31/2001 | CN1282378A Analyte assay using particulate labels |
| 01/31/2001 | CN1282374A Bacterial resistance in grapevine |
| 01/31/2001 | CN1282373A Method for producing amylase enzymes |
| 01/31/2001 | CN1282372A Mammalian sytokine-like polypeptide-10 |
| 01/31/2001 | CN1282371A Ac (DNA encoding C6 beta-chemokine leukotactin-1 (Lkn-1) isolated from human |
| 01/31/2001 | CN1282369A Polypeptides having aminopepyidase activity and nucleic acids encoding same |
| 01/31/2001 | CN1282339A Monoclonal antibody to alpha 2-macroglobulin and its use for detecting glucan |
| 01/31/2001 | CN1282338A A DNA molecule encoding mutant prepro-neuropeptide Y, a mutant signal peptide, and uses thereof |
| 01/31/2001 | CN1282255A IFNAR2/I FN complex |
| 01/31/2001 | CN1281899A Human tumor related gene in region of sub-band 3 of band 3 of zone 1 of human chromosome No.17 |
| 01/31/2001 | CN1281898A Human zinc finger protein isomer and its code sequence |
| 01/31/2001 | CN1281897A Human thioredoxin related protein and its code sequence |
| 01/31/2001 | CN1281896A Human nuclear receptor factor protein an its code sequence |
| 01/31/2001 | CN1281895A Human mitochondrial solute carrier protein isomer and its code sequence |
| 01/31/2001 | CN1281894A Method for transferring human endostatin gene lactic bacteria, its product and application |
| 01/31/2001 | CN1281893A Truncated type human insulin-like growth factor-I double gene copy engineering strain and its construction method |
| 01/31/2001 | CN1281863A Recombinant Newcastle disease virus capable of being used as embryo vaccine |
| 01/31/2001 | CN1281862A Three-chain formed oligonucleotide capable of inhibiting platelet derived growth factor gene expression and its application |
| 01/31/2001 | CN1281636A Method for raising rice yield potentiality |
| 01/31/2001 | CN1061377C Monobleb viras carrier capable of being used in packaging recombination of adenovirus concomitant virus and use thereof |
| 01/31/2001 | CN1061376C Chimeric regulatory regions and gene cassettes for expression of genes in plants |